Xi'an, China

Boyang Li

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):

Title: Boyang Li: Innovator in Medicinal Chemistry

Introduction

Boyang Li is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit coronavirus activity. His innovative work has the potential to impact the treatment of viral infections, including COVID-19.

Latest Patents

Boyang Li holds a patent for a compound known as 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione. This compound is designed to inhibit the activity of the coronavirus 3CL protease. The invention details a method for preparing this compound, which has shown effectiveness in blocking the replication and transcription of SARS-CoV-2 viruses in patients. The compound is noted for its high in-vitro safety and promising application in the development of anti-SARS-CoV-2 drugs.

Career Highlights

Throughout his career, Boyang Li has worked with notable companies such as Shaanxi Panlong Pharmaceutical Co., Ltd. and Xixian New District Fenghou Original Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Boyang Li has collaborated with several professionals in his field, including Xiaolin Xie and Dezhu Zhang. These partnerships have facilitated the advancement of his research and the successful development of his patented compounds.

Conclusion

Boyang Li is a dedicated inventor whose work in medicinal chemistry is paving the way for new treatments against viral infections. His innovative approaches and collaborations highlight the importance of research in combating global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…